Literature DB >> 28549090

Sigma-1 Receptor Regulates Mitochondrial Function in Glucose- and Oxygen-Deprived Retinal Ganglion Cells.

Dorette Z Ellis1, Linya Li2, Yong Park2, Shaoqing He2, Brett Mueller3, Thomas Yorio2.   

Abstract

Purpose: Understanding the role of mitochondria in retinal ganglion cells (RGCs) is relevant to human disease as studies have shown mitochondrial abnormalities in primary open-angle glaucoma patients. This study seeks to determine the effects of the sigma-1 receptor (σ-1r) and its agonists on mitochondrial function in oxygen- and glucose- deprived (OGD) purified neonatal RGCs.
Methods: Retinal ganglion cells were isolated from rat pups and subjected to OGD in varying conditions in the presence or absence of σ-1r agonist and antagonist and following addition of an AAV2-σ-1r vector that was used to increase σ-1r expression. Western blots and immunofluorescence microscopy validated findings. Mitochondrial function was determined by measuring mitochondrial membrane potential (Δψm) using the dye, fluorescence tetraethylbenzimidazolylcarbocyanineiodide (JC-1), and determination of cytochrome c oxidase activity using a cytochrome c oxidase assay kit. Caspase 3 and 7 activities were also measured using a luminescent assay kit.
Results: Oxygen and glucose deprivation in RGCs resulted in decreased mitochondrial membrane potential and cytochrome c oxidase activity when compared with normoxic RGCs. σ-1r agonists or overexpression of the σ-1r restored the mitochondrial membrane potential comparable to normoxic conditions, while σ-1r antagonists abolished these effects. Oxygen and glucose depreavtation induced decreases in cytochrome c activity were partially restored by overexpression or activation of σ-1r. Caspase activity was increased in response to OGD and was decreased by the addition of σ-1r agonist, pentazocine, and following σ-1r overexpression. Conclusions: These data suggest that activation and/or overexpression of σ-1r restores RGCs mitochondrial function following OGD and that mitochondrial function is vital to the function of RGCs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28549090     DOI: 10.1167/iovs.16-19199

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

2.  Enhanced Physiological Stress Response in Patients with Normal Tension Glaucoma during Hypoxia.

Authors:  Line Marie Dalgaard; Jeppe Vibæk; Rupali Vohra; Lars Thorbjørn Jensen; Barbara Cvenkel; Niels H Secher; Niels Vidiendal Olsen; Miriam Kolko
Journal:  J Ophthalmol       Date:  2021-04-07       Impact factor: 1.909

Review 3.  Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Mahboob Morshed; Naznin Sultana Remex; Md Shenuarin Bhuiyan
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

4.  Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling.

Authors:  Jia Liu; Xue Gong; Xingwang Zhu; Dongwei Xue; Yili Liu; Ping Wang
Journal:  Oncotarget       Date:  2017-09-08

5.  Activation of Sigma 1 Receptor Extends Survival of Cones and Improves Visual Acuity in a Murine Model of Retinitis Pigmentosa.

Authors:  Jing Wang; Alan Saul; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-10-01       Impact factor: 4.925

6.  Comparison of Sigma 1 Receptor Ligands SA4503 and PRE084 to (+)-Pentazocine in the rd10 Mouse Model of RP.

Authors:  Jing Wang; Haiyan Xiao; Shannon R Barwick; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

Review 7.  Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?

Authors:  José Miguel Vela
Journal:  Front Pharmacol       Date:  2020-11-09       Impact factor: 5.810

8.  Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma.

Authors:  Michal Geva; Noga Gershoni-Emek; Luana Naia; Philip Ly; Sandra Mota; Ana Cristina Rego; Michael R Hayden; Leonard A Levin
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

Review 9.  Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms.

Authors:  Zifen Xu; Yushuang Lei; Huan Qin; Shiyao Zhang; Ping Li; Kai Yao
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.